AMANDA CARDOZA: Open Payments
NPI 1831780311 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,071 in 177 payments from 22 companies in 2025. Trend: 2023 $2,108 · 2024 $3,548 · 2025 $4,071
Food & beverage: $3,812Education: $259
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 22 | $547 |
| ABBVIE INC. | 18 | $468 |
| UCB, Inc. | 9 | $383 |
| Regeneron Healthcare Solutions, Inc. | 17 | $324 |
| Incyte Corporation | 15 | $293 |
| Janssen Biotech, Inc. | 11 | $271 |
| Amgen Inc. | 11 | $252 |
| Lilly USA, LLC | 8 | $247 |
| Novartis Pharmaceuticals Corporation | 9 | $200 |
| E.R. Squibb & Sons, L.L.C. | 11 | $200 |
Products named: NEMLUVIO, DUPIXENT, Bimzelx, OPZELURA, TREMFYA, OTEZLA, Sotyktu, BOTOX.
Industry payments across TX — which companies pay providers there.
